![Donald Picker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Donald Picker
Fondateur chez
MOLECULIN BIOTECH, INC.
Fortune : 112 466 $ au 31/08/2026
Profil
Donald H.
Picker is the founder of Moleculin Biotech, Inc., founded in 2015, where the title held is Chief Scientific Officer.
Current jobs include Chief Executive Officer & Director at Sinapis Pharma, Inc., President & Chief Operating Officer at Moleculin LLC since 2007, and Chief Technology Officer at Secure Voice Communications, Inc. since 2007.
Former jobs include Chief Executive Officer at Synergy Pharmaceuticals, Inc. from 1998 to 2003; Chief Executive Officer at Intertech Bio; Vice Chairman & President at Interactive Therapeutics, Inc.; Director at Cardiff Oncology, Inc. in 2009; President, Chief Operating Officer & Director at Breitling Energy Corp.; Director at CNS Pharmaceuticals, Inc. from 2018 to 2019; President & Chief Operating Officer at Tapestry Pharmaceuticals, Inc. from 2006 to 2007; Vice President-Research & Development at Callisto Pharmaceuticals, Inc. from 2001 to 2006; Executive Vice President-Research & Development at Genta, Inc.; and Chief Operating Officer at Edgeline Holdings, Inc. from 2007 to 2008.
Education includes a doctorate from State University of New York at Albany conferred in 1975 and an undergraduate degree from New York University Tandon School of Engineering.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/08/2026 | 174 366 ( 0,9 % ) | 112 466 $ | 31/08/2026 |
Postes actifs de Donald Picker
| Sociétés | Poste | Début |
|---|---|---|
| MOLECULIN BIOTECH, INC. | Fondateur | 28/07/2015 |
Secure Voice Communications, Inc.
 Secure Voice Communications, Inc. Internet Software/ServicesTechnology Services Develops VoIP technologies | Directeur Technique/Scientifique/R&D | 01/11/2007 |
Sinapis Pharma, Inc.
 Sinapis Pharma, Inc. BiotechnologyHealth Technology Provides biotechnology services | Directeur Général | 18/11/2009 |
Moleculin LLC
 Moleculin LLC Pharmaceuticals: MajorHealth Technology Develops dermatological products for treatment of skin disorders | President | 01/01/2007 |
Anciens postes connus de Donald Picker
| Sociétés | Poste | Fin |
|---|---|---|
| CARDIFF ONCOLOGY, INC. | Directeur/Membre du Conseil | 28/05/2009 |
| BREITLING ENERGY CORP | President | 20/11/2008 |
Edgeline Holdings, Inc.
 Edgeline Holdings, Inc. Pharmaceuticals: MajorHealth Technology Prepares pharmaceutical products. | Directeur des opérations | 24/03/2008 |
Tapestry Pharmaceuticals, Inc.
 Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel | President | 26/10/2007 |
Callisto Pharmaceuticals, Inc.
 Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops novel therapeutics to treat cancer | Directeur Technique/Scientifique/R&D | 01/12/2006 |
Formation de Donald Picker
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
55
Relations au 1er degré
16
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 16 |
|---|---|
Tapestry Pharmaceuticals, Inc.
Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel | Health Technology |
Callisto Pharmaceuticals, Inc.
Callisto Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops novel therapeutics to treat cancer | Health Technology |
Genta, Inc.
 Genta, Inc. Pharmaceuticals: MajorHealth Technology Engages in pharmaceutical research and development | Health Technology |
Edgeline Holdings, Inc.
Edgeline Holdings, Inc. Pharmaceuticals: MajorHealth Technology Prepares pharmaceutical products. | Health Technology |
Moleculin LLC
Moleculin LLC Pharmaceuticals: MajorHealth Technology Develops dermatological products for treatment of skin disorders | Health Technology |
Synergy Pharmaceuticals, Inc. /Old/
 Synergy Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Researches and develops drugs to treat hepatitis C, hepatitis B, epilepsy and brain cancer | Health Technology |
Cardiff Oncology, Inc.
 Cardiff Oncology, Inc. Medical SpecialtiesHealth Technology Develops diagnostic products | Health Technology |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Secure Voice Communications, Inc.
Secure Voice Communications, Inc. Internet Software/ServicesTechnology Services Develops VoIP technologies | Technology Services |
Interactive Therapeutics, Inc.
 Interactive Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops products to treat cancer, infectious diseases and other medical conditions associated with compromised immune systems. | Health Technology |
Intertech Bio
 Intertech Bio Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
Breitling Energy Corp.
 Breitling Energy Corp. Real Estate Investment TrustsFinance Acts as a Real Estate Investment Trust/REIT | Finance |
New York University Tandon School of Engineering
 New York University Tandon School of Engineering Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Sinapis Pharma, Inc.
Sinapis Pharma, Inc. BiotechnologyHealth Technology Provides biotechnology services | Health Technology |
Moleculin Biotech, Inc.
 Moleculin Biotech, Inc. Pharmaceuticals: MajorHealth Technology Engages in the development of treatments for highly resistant cancers and viruses | Health Technology |
CNS Pharmaceuticals, Inc.
 CNS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets pharmaceutical drugs | Health Technology |
